The value of PSQ, as shown in our analyses, is supported by Karayan-Tapon et al. who evaluated MGMT promoter methylation assessment by MSP, semi-quantitative MSP, PSQ, qRT-PCR, and IHC for their value of predicting OS in glioblastoma patients. Here, MGMT is linked to glioblastoma.